Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 24 | 2024 | 5686 | 3.260 |
Why?
|
Carcinoma, Squamous Cell | 12 | 2024 | 4034 | 2.380 |
Why?
|
Cytokines | 15 | 2023 | 7322 | 1.610 |
Why?
|
Scleroderma, Systemic | 2 | 2023 | 323 | 1.310 |
Why?
|
Skin | 11 | 2023 | 4364 | 1.230 |
Why?
|
Receptors, Notch | 6 | 2020 | 739 | 1.140 |
Why?
|
Dermatitis, Allergic Contact | 2 | 2019 | 104 | 1.050 |
Why?
|
Carcinogens | 3 | 2023 | 466 | 1.020 |
Why?
|
Cancer Vaccines | 2 | 2022 | 1023 | 0.970 |
Why?
|
Epidermis | 4 | 2019 | 528 | 0.910 |
Why?
|
Colitis | 2 | 2023 | 1170 | 0.880 |
Why?
|
Smad6 Protein | 1 | 2021 | 15 | 0.800 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2023 | 2988 | 0.790 |
Why?
|
Killer Cells, Natural | 4 | 2023 | 2133 | 0.780 |
Why?
|
Alphapapillomavirus | 2 | 2020 | 221 | 0.760 |
Why?
|
Lichen Planus | 1 | 2020 | 57 | 0.700 |
Why?
|
Melanoma, Experimental | 1 | 2023 | 561 | 0.690 |
Why?
|
Skin Physiological Phenomena | 1 | 2020 | 180 | 0.680 |
Why?
|
Langerhans Cells | 1 | 2019 | 173 | 0.680 |
Why?
|
Papillomaviridae | 3 | 2020 | 1119 | 0.670 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2018 | 49 | 0.630 |
Why?
|
Chemokines, CXC | 1 | 2019 | 422 | 0.630 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 849 | 0.610 |
Why?
|
Extracellular Matrix | 2 | 2022 | 1741 | 0.610 |
Why?
|
Immunotherapy | 7 | 2024 | 4445 | 0.590 |
Why?
|
Symbiosis | 1 | 2019 | 287 | 0.590 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 820 | 0.560 |
Why?
|
Virus Diseases | 1 | 2022 | 711 | 0.560 |
Why?
|
Immunity, Cellular | 3 | 2017 | 1607 | 0.540 |
Why?
|
Keratosis, Actinic | 1 | 2016 | 74 | 0.540 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2023 | 934 | 0.540 |
Why?
|
Th2 Cells | 2 | 2022 | 1061 | 0.520 |
Why?
|
Keratinocytes | 7 | 2023 | 798 | 0.480 |
Why?
|
Skin Diseases | 1 | 2023 | 1065 | 0.480 |
Why?
|
Mice | 30 | 2024 | 81183 | 0.470 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2849 | 0.470 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13102 | 0.470 |
Why?
|
Fluorouracil | 5 | 2023 | 1619 | 0.450 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2023 | 4386 | 0.440 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2016 | 520 | 0.440 |
Why?
|
Organ Transplantation | 2 | 2022 | 1139 | 0.440 |
Why?
|
Melanoma | 4 | 2023 | 5510 | 0.400 |
Why?
|
Precancerous Conditions | 2 | 2016 | 975 | 0.400 |
Why?
|
HLA Antigens | 3 | 2023 | 1381 | 0.390 |
Why?
|
Sarcoma | 1 | 2022 | 1897 | 0.380 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2021 | 4479 | 0.370 |
Why?
|
Calcitriol | 4 | 2023 | 298 | 0.370 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 4 | 2020 | 121 | 0.370 |
Why?
|
Health Promotion | 1 | 2022 | 2205 | 0.360 |
Why?
|
Monocytes | 1 | 2019 | 2596 | 0.360 |
Why?
|
Signal Transduction | 10 | 2022 | 23403 | 0.360 |
Why?
|
Hair Follicle | 2 | 2009 | 209 | 0.350 |
Why?
|
Receptor, Notch1 | 3 | 2010 | 502 | 0.350 |
Why?
|
Animals | 32 | 2024 | 168757 | 0.350 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1587 | 0.310 |
Why?
|
Inflammation | 4 | 2022 | 10638 | 0.290 |
Why?
|
Leukemia, Mast-Cell | 1 | 2006 | 14 | 0.280 |
Why?
|
Immunocompromised Host | 2 | 2022 | 847 | 0.270 |
Why?
|
Dermatitis, Atopic | 2 | 2010 | 654 | 0.260 |
Why?
|
Humans | 48 | 2023 | 744343 | 0.260 |
Why?
|
Fibrosis | 2 | 2023 | 2029 | 0.260 |
Why?
|
Genes, Tumor Suppressor | 1 | 2009 | 1097 | 0.250 |
Why?
|
Stromal Cells | 2 | 2009 | 1355 | 0.250 |
Why?
|
Lymphoproliferative Disorders | 1 | 2008 | 523 | 0.250 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20822 | 0.240 |
Why?
|
Neoplasms | 6 | 2023 | 21683 | 0.240 |
Why?
|
Mastocytosis | 1 | 2006 | 160 | 0.230 |
Why?
|
Collagen | 2 | 2022 | 2689 | 0.230 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11524 | 0.230 |
Why?
|
Xeroderma Pigmentosum | 1 | 2023 | 31 | 0.230 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5256 | 0.220 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 6773 | 0.220 |
Why?
|
Adaptive Immunity | 3 | 2019 | 713 | 0.220 |
Why?
|
Mice, Knockout | 9 | 2019 | 14557 | 0.210 |
Why?
|
Bleomycin | 1 | 2022 | 512 | 0.190 |
Why?
|
Cell Line, Tumor | 7 | 2022 | 16689 | 0.190 |
Why?
|
Dendritic Cells | 2 | 2023 | 2725 | 0.190 |
Why?
|
Cell Differentiation | 5 | 2023 | 11483 | 0.180 |
Why?
|
Antigens, Neoplasm | 2 | 2019 | 1988 | 0.180 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 164 | 0.180 |
Why?
|
Nevus, Pigmented | 1 | 2022 | 219 | 0.180 |
Why?
|
Allergy and Immunology | 1 | 2021 | 169 | 0.180 |
Why?
|
Cell Lineage | 1 | 2009 | 2504 | 0.180 |
Why?
|
Interleukin-13 | 1 | 2022 | 389 | 0.180 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13695 | 0.180 |
Why?
|
Receptors, CCR6 | 1 | 2019 | 81 | 0.170 |
Why?
|
Mannose-Binding Lectins | 1 | 2019 | 100 | 0.170 |
Why?
|
Arginine | 1 | 2023 | 944 | 0.170 |
Why?
|
Chronic Disease | 4 | 2019 | 9146 | 0.170 |
Why?
|
Paget Disease, Extramammary | 1 | 2019 | 45 | 0.170 |
Why?
|
Ultraviolet Rays | 2 | 2024 | 1060 | 0.160 |
Why?
|
Administration, Topical | 2 | 2019 | 690 | 0.160 |
Why?
|
Cytomegalovirus | 1 | 2023 | 732 | 0.160 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2018 | 159 | 0.160 |
Why?
|
Exanthema | 1 | 2023 | 501 | 0.160 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2022 | 1369 | 0.160 |
Why?
|
Lasers | 2 | 2024 | 952 | 0.150 |
Why?
|
STAT3 Transcription Factor | 1 | 2022 | 873 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.150 |
Why?
|
DNA Virus Infections | 1 | 2017 | 13 | 0.150 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1613 | 0.150 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 164 | 0.150 |
Why?
|
Genes, MHC Class II | 1 | 2018 | 457 | 0.150 |
Why?
|
Th1 Cells | 1 | 2022 | 1057 | 0.150 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18029 | 0.150 |
Why?
|
Cell Count | 2 | 2019 | 1856 | 0.150 |
Why?
|
Lectins, C-Type | 1 | 2019 | 588 | 0.140 |
Why?
|
Lasers, Gas | 1 | 2017 | 93 | 0.140 |
Why?
|
Female | 19 | 2022 | 380194 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1821 | 0.130 |
Why?
|
Stem Cells | 1 | 2009 | 3567 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1366 | 0.130 |
Why?
|
B-Lymphocytes | 2 | 2008 | 4665 | 0.130 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.130 |
Why?
|
Epithelium | 1 | 2020 | 1679 | 0.130 |
Why?
|
Neutrophil Infiltration | 1 | 2017 | 390 | 0.130 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 21827 | 0.130 |
Why?
|
Immunity | 2 | 2017 | 1012 | 0.120 |
Why?
|
Physicians | 2 | 2023 | 4567 | 0.120 |
Why?
|
Disease Progression | 2 | 2020 | 13284 | 0.120 |
Why?
|
Nickel | 1 | 2014 | 130 | 0.120 |
Why?
|
Internal Fixators | 1 | 2014 | 188 | 0.120 |
Why?
|
Oncogenes | 1 | 2019 | 1265 | 0.120 |
Why?
|
Fibroblasts | 2 | 2023 | 4161 | 0.110 |
Why?
|
Lymphocytes | 1 | 2021 | 2617 | 0.110 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 545 | 0.110 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 2007 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2021 | 2942 | 0.110 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2699 | 0.110 |
Why?
|
Psoriasis | 1 | 2020 | 898 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2021 | 2969 | 0.100 |
Why?
|
Aged | 7 | 2023 | 163280 | 0.100 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3586 | 0.100 |
Why?
|
Neoplasm Metastasis | 1 | 2022 | 4851 | 0.100 |
Why?
|
RNA, Viral | 1 | 2019 | 2902 | 0.100 |
Why?
|
Middle Aged | 8 | 2019 | 213383 | 0.090 |
Why?
|
Dermatitis | 1 | 2012 | 197 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2005 | 776 | 0.090 |
Why?
|
Pruritus | 1 | 2013 | 361 | 0.090 |
Why?
|
Asthma | 1 | 2009 | 6011 | 0.090 |
Why?
|
Desmogleins | 1 | 2009 | 3 | 0.090 |
Why?
|
Dermatology | 1 | 2020 | 872 | 0.090 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2009 | 62 | 0.090 |
Why?
|
Genes, ras | 1 | 2012 | 690 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2019 | 57776 | 0.090 |
Why?
|
Up-Regulation | 1 | 2019 | 4217 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2021 | 2958 | 0.090 |
Why?
|
Cell Line | 2 | 2021 | 15997 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2043 | 0.080 |
Why?
|
Antigens, CD | 1 | 2019 | 4026 | 0.080 |
Why?
|
Sensory Receptor Cells | 1 | 2013 | 492 | 0.080 |
Why?
|
Lung | 2 | 2023 | 9856 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2021 | 3690 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9734 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2265 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10180 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 821 | 0.080 |
Why?
|
Cell Movement | 1 | 2019 | 5217 | 0.080 |
Why?
|
Keratins | 1 | 2009 | 515 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3647 | 0.070 |
Why?
|
Osteopontin | 1 | 2009 | 296 | 0.070 |
Why?
|
Hair | 1 | 2009 | 483 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3309 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2541 | 0.070 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 642 | 0.060 |
Why?
|
Neutrophils | 1 | 2017 | 3719 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2019 | 12026 | 0.060 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2008 | 584 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2008 | 1588 | 0.060 |
Why?
|
Hypersensitivity | 1 | 2013 | 1102 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3481 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3493 | 0.060 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 606 | 0.060 |
Why?
|
Male | 9 | 2021 | 350118 | 0.060 |
Why?
|
Apoptosis | 1 | 2019 | 9727 | 0.060 |
Why?
|
Survival Analysis | 3 | 2017 | 10252 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2005 | 434 | 0.060 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2008 | 2726 | 0.050 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2023 | 131 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2008 | 10481 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5319 | 0.050 |
Why?
|
Gene Deletion | 1 | 2009 | 2751 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2006 | 1880 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2017 | 6386 | 0.050 |
Why?
|
Pyrimidinones | 1 | 2023 | 371 | 0.050 |
Why?
|
Longevity | 1 | 2008 | 1070 | 0.050 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 689 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 648 | 0.040 |
Why?
|
Cell Communication | 1 | 2007 | 1621 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2421 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2010 | 5974 | 0.040 |
Why?
|
Azacitidine | 1 | 2020 | 347 | 0.040 |
Why?
|
Research Personnel | 1 | 2023 | 573 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15519 | 0.040 |
Why?
|
Mentors | 1 | 2023 | 631 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 2025 | 0.040 |
Why?
|
Blotting, Western | 1 | 2006 | 5179 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 712 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2022 | 2085 | 0.040 |
Why?
|
Homeostasis | 1 | 2009 | 3340 | 0.040 |
Why?
|
Photolysis | 1 | 2017 | 92 | 0.040 |
Why?
|
Piperazines | 2 | 2005 | 2488 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 271 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 12072 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5535 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1660 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2017 | 793 | 0.030 |
Why?
|
Gene Frequency | 2 | 2017 | 3588 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 53288 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1878 | 0.030 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2013 | 38 | 0.030 |
Why?
|
Receptors, Bombesin | 1 | 2013 | 27 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3798 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1276 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 56430 | 0.030 |
Why?
|
Pyrimidines | 1 | 2005 | 2942 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2599 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2013 | 236 | 0.030 |
Why?
|
Leadership | 1 | 2021 | 1357 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1038 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4554 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2023 | 3023 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 1915 | 0.030 |
Why?
|
Genotype | 2 | 2018 | 12951 | 0.020 |
Why?
|
Mutation | 3 | 2023 | 29786 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1349 | 0.020 |
Why?
|
Epitopes | 1 | 2017 | 2571 | 0.020 |
Why?
|
Laser Therapy | 1 | 2017 | 1072 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2005 | 5172 | 0.020 |
Why?
|
Nociceptors | 1 | 2013 | 432 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2278 | 0.020 |
Why?
|
Receptor, Notch2 | 1 | 2010 | 89 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12208 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 261 | 0.020 |
Why?
|
Risk Factors | 4 | 2020 | 72290 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5867 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40561 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2018 | 12261 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 399 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3703 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2013 | 1463 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 648 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2133 | 0.020 |
Why?
|
Somatomedins | 1 | 2007 | 192 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3528 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Adult | 2 | 2019 | 214055 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 2007 | 402 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2010 | 881 | 0.020 |
Why?
|
DNA Methylation | 1 | 2020 | 4286 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 2957 | 0.020 |
Why?
|
Pregnancy | 1 | 2008 | 29144 | 0.020 |
Why?
|
Time Factors | 1 | 2008 | 40075 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1526 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4328 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1222 | 0.020 |
Why?
|
Spinal Cord | 1 | 2013 | 1809 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3749 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8428 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1549 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2004 | 356 | 0.010 |
Why?
|
Melanocytes | 1 | 2007 | 515 | 0.010 |
Why?
|
Tandem Repeat Sequences | 1 | 2004 | 185 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3689 | 0.010 |
Why?
|
Karyotyping | 1 | 2005 | 1243 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 77449 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.010 |
Why?
|
Mitosis | 1 | 2007 | 1208 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6933 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1157 | 0.010 |
Why?
|
Clone Cells | 1 | 2005 | 1692 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 651 | 0.010 |
Why?
|
Mutagenesis | 1 | 2005 | 1266 | 0.010 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2004 | 491 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7799 | 0.010 |
Why?
|
Benzamides | 1 | 2005 | 1379 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6622 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2005 | 1836 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3846 | 0.010 |
Why?
|
Quinazolines | 1 | 2004 | 1356 | 0.010 |
Why?
|
Cell Division | 1 | 2005 | 4568 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2007 | 2948 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2513 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4186 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2765 | 0.010 |
Why?
|
Cell Cycle | 1 | 2004 | 2967 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2455 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2004 | 4776 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12788 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7722 | 0.010 |
Why?
|
Graft Survival | 1 | 2004 | 3737 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8436 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9583 | 0.010 |
Why?
|
Rats | 1 | 2009 | 24260 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12245 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14722 | 0.010 |
Why?
|
United States | 1 | 2017 | 69872 | 0.010 |
Why?
|